Elevated pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in cholangiocarcinoma: A large-scale meta-analysis of 48 cohorts

doi:10.4251/wjgo.124040

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 11

This Article

(9)

(0)

(196)

Peer-Review Report of This Article

Supplementary Materials of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Nov 15, 2026; 18(11): 124040
Published online Nov 15, 2026. doi: 10.4251/wjgo.124040

Full Size Figure Download Figure

Figure 1 Prognostic value of pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte on overall survival. A: Prognostic value of pretreatment neutrophil-to-lymphocyte ratio on overall survival; B: Prognostic value of pretreatment platelet-to-lymphocyte ratio on overall survival. HR: Hazard ratio; CI: Confidence interval.

Citation: Cai WM, Jiang W, He BF, Yu JJ, Zeng XH, Peng L, Liu S. Elevated pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in cholangiocarcinoma: A large-scale meta-analysis of 48 cohorts. World J Gastrointest Oncol 2026; 18(11): 124040
URL: https://www.wjgnet.com/1948-5204/full/v18/i11/124040.htm
DOI: https://dx.doi.org/10.4251/wjgo.124040

Cai WM, Jiang W, He BF, Yu JJ, Zeng XH, Peng L, Liu S. Elevated pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in cholangiocarcinoma: A large-scale meta-analysis of 48 cohorts. World J Gastrointest Oncol 2026; 18(11): 124040 [DOI: 10.4251/wjgo.124040]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.